IMMUNOME INC (IMNM)

US45257U1088 - Common Stock

10.91  -0.68 (-5.87%)

News Image
2 months ago - Market News Video

Immunome (IMNM) Shares Cross Above 200 DMA

News Image
3 months ago - Investor's Business Daily

Immunome Stock Sees RS Rating Jump To 91

Immunome stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an upgrade from 88 to 91.

News Image
3 months ago - InvestorPlace

IMNM Stock Earnings: Immunome Misses EPS, Misses Revenue for Q2 2024

IMNM stock results show that Immunome missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

News Image
3 months ago - BusinessInsider

IMNM Stock Earnings: Immunome Misses EPS, Misses Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Immunome (NASDAQ:IMNM) just reported results for the second quarter of 2024.Imm...

News Image
4 months ago - Nectin Therapeutics

Nectin Therapeutics Licenses Novel Antibodies to Immunome

/PRNewswire/ -- Nectin Therapeutics, Ltd., a biotechnology company developing novel immunotherapies and antibody drug conjugates (ADC) to address tumor...

News Image
5 months ago - Market News Video

Oversold Conditions For Immunome (IMNM)

News Image
6 months ago - Market News Video

Wednesday 5/22 Insider Buying Report: IMNM, CMI

News Image
6 months ago - InvestorPlace

IMNM Stock Earnings: Immunome Beats EPS, Misses Revenue for Q1 2024

IMNM stock results show that Immunome beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image
7 months ago - Market News Video

RSI Alert: Immunome (IMNM) Now Oversold